Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency

Translational Research

Volumn 162, Issue 2, 2013, Pages 67-76

  Betz, Boris ^a   Möller Ehrlich, Kerstin ^a   Kress, Tobias ^a   Kniepert, Joachim ^a   Schwedhelm, Edzard ^b   Böger, Rainer H ^b   Wanner, Christoph ^a   Sauvant, Christoph ^c   Schneider, Reinhard ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOHIPPURIC ACID; 6 N,N' DIMETHYLARGININE; AMINO ACID TRANSPORTER; ARGININE; CATION; HYDROLASE; MESSENGER RNA; METHYLTRANSFERASE;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARGININE DEFICIENCY; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GLOMERULUS FILTRATION RATE; KIDNEY CLEARANCE; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY PLASMA FLOW; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERUM; WESTERN BLOTTING;

EID: 84880573797     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2013.04.005     Document Type: Article

References (37)

1. S. Uchino, J.A. Kellum, and R. Bellomo Acute renal failure in critically ill patients: a multinational, multicenter study JAMA 294 2005 813 818
2. R.W. Schrier, W. Wang, B. Poole, and A. Mitra Acute renal failure: definitions, diagnosis, pathogenesis, and therapy J Clin Invest 114 2004 5 14
3. M.S. Goligorsky, S.V. Brodsky, and E. Noiri Nitric oxide in acute renal failure: NOS versus NOS Kidney Int 61 2002 855 861
4. B. Betz, R. Schneider, T. Kress, M.A. Schick, C. Wanner, and C. Sauvant Rosiglitazone affects nitric oxide synthases and improves renal outcome in a rat model of severe ischemia/reperfusion injury PPAR Res 2012 10.1155/2012/219319
5. R. Schneider, U. Raff, and N. Vornberger L-arginine counteracts nitric oxide deficiency and improves the recovery phase of ischemic acute renal failure in rats Kidney Int 64 2003 216 225
6. S.M. Bode-Böger, F. Scalera, and L.J. Ignarro The L-arginine paradox: importance of the L-arginine/asymmetrical dimethylarginine ratio Pharmacol Ther 114 2007 295 306
7. P. Bulau, D. Zakrzewicz, and K. Kitowska Analysis of methylarginine metabolism in the cardiovascular system identifies the lung as a major source of ADMA Am J Physiol Lung Cell Mol Physiol 292 1 2007 L18 L24
8. J.T. Kielstein, D. Fliser, and H. Veldink Asymmetric dimethylarginine and symmetric dimethylarginine: axis of evil or useful alliance? Semin Dial 22 2009 346 350
9. E.I. Closs, F.Z. Basha, A. Habermeier, and U. Förstermann Interference of L-arginine analogues with L-arginine transport mediated by the y+ carrier hCAT-2B Nitric Oxide 1 1997 65 73
10. M. Busch, C. Fleck, G. Wolf, and G. Stein Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease: possible candidates for paradoxical epidemiology? Amino Acids 30 2006 225 232
11. C.-N. Hsu, L.-T. Huang, Y.-T. Lau, C.-Y. Lin, and Y.-L. Tain The combined ratios of L-arginine and asymmetric and symmetric dimethylarginine as biomarkers in spontaneously hypertensive rats Transl Res 159 2012 90 98
12. C. Zoccali, S. Bode-Böger, and F. Mallamaci Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study Lancet 358 2001 2113 2117
13. S.M. Bode-Böger, F. Scalera, and J.T. Kielstein Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease J Am Soc Nephrol 17 2006 1128 1134
14. G. Li Volti, V. Sorrenti, and R. Acquaviva Effect of ischemia-reperfusion on renal expression and activity of N(G)-N(G)-dimethylarginine dimethylaminohydrolases Anesthesiology 109 2008 1054 1062
15. E. Schwedhelm, R. Maas, J. Tan-Andresen, F., Schulze, U., Riederer, and R.H. Böger High-throughput liquid chromatographic-tandem mass spectrometric determination of arginine and dimethylated arginine derivatives in human and mouse plasma J Chromatogr B Analyt Technol Biomed Life Sci 851 2007 211 219
16. H. He, X. Li, and H. Wang Effects of salvianolic acid A on plasma and tissues dimethylarginine levels in a rat model of myocardial infarction J Cardiovasc Pharmacol 2013 10.1097/FJC 0b013e3182893fd5
17. T. Ogawa, M. Kimoto, and K. Sasaoka Occurrence of a new enzyme catalyzing the direct conversion of NG, NG-dimethyl-L-arginine to L-citrulline in rats Biochem Biophys Res Commun 148 1987 671 677
18. R.J. Nijveldt, T. Teerlink, and C. van Guldener Handling of asymmetrical dimethylarginine and symmetrical dimethylarginine by the rat kidney under basal conditions and during endotoxaemia Nephrol Dial Transplant 18 2003 2542 2550
19. F. Palm, M.L. Onozato, Z. Luo, and C.S. Wilcox Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems Am J Physiol Heart Circ Physiol 293 2007 H3227 H3245
20. M.T. Bedford, and S.G. Clarke Protein arginine methylation in mammals: who, what, and why Mol Cell 33 2009 1 13
21. J. Tang, A. Frankel, and R.J. Cook PRMT1 is the predominant type I protein arginine methyltransferase in mammalian cells J Biol Chem 275 2000 7723 7730
22. E.I. Closs, J.-P. Boissel, A. Habermeier, and A. Rotmann Structure and function of cationic amino acid transporters (CATs) J Membr Biol 213 2006 67 77
23. S. Xiao, L. Wagner, J. Mahaney, and C. Baylis Uremic levels of urea inhibit L-arginine transport in cultured endothelial cells Am J Physiol Renal Physiol 280 2001 F989 F995
24. I.F. Schwartz, D. Schwartz, and M. Traskonov L-arginine transport is augmented through up-regulation of tubular CAT-2 mRNA in ischemic acute renal failure in rats Kidney Int 62 2002 1700 1706
25. K.K. McDonald, S. Zharikov, E.R. Block, and M.S. Kilberg A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric-oxide synthase may explain the "arginine paradox." J Biol Chem 272 1997 31213 31216
26. L. Schramm, M. La, and E. Heidbreder L-arginine deficiency and supplementation in experimental acute renal failure and in human kidney transplantation Kidney Int 61 2002 1423 1432
27. C. Baylis Nitric oxide deficiency in chronic kidney disease Am J Physiol Renal Physiol 294 2008 F1 F9
28. H. Kosaka, H. Yoneyama, L. Zhang, S. Fujii, A. Yamamoto, and J. Igarashi Induction of LOX-1 and iNOS expressions by ischemia-reperfusion of rat kidney and the opposing effect of L-arginine FASEB J 17 2003 636 643
29. K. Matsuguma, S. Ueda, and S.I. Yamagishi Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease J Am Soc Nephrol 17 2006 2176 2183
30. M. Al Banchaabouchi, B. Marescau, I. Possemiers, R. D'Hooge, O. Levillain, and P.P. De Deyn NG, NG-dimethylarginine and NG, NG-dimethylarginine in renal insufficiency Pflugers Arch 439 2000 524 531
31. A.J. Cardounel, H. Cui, and A. Samouilov Evidence for the pathophysiological role of endogenous methylarginines in regulation of endothelial NO production and vascular function J Biol Chem 282 2007 879 887
32. J.T. Kielstein, S.R. Salpeter, S.M. Bode-Boeger, J.P. Cooke, and D. Fliser Symmetric dimethylarginine (SDMA) as endogenous marker of renal function: a meta-analysis Nephrol Dial Transplant 21 2006 2446 2451
33. E.L. Rhoden, L. Pereira-Lima, C.R. Rhoden, M.L. Lucas, C. Telöken, and A. Belló-Klein Role of the L-arginine/nitric oxide pathway in renal ischaemia-reperfusion in rats Eur J Surg 167 2001 224 228
34. D. Tsikas, R.H. Böger, J. Sandmann, S.M. Bode-Böger, and J.C. Frölich Endogenous nitric oxide synthase inhibitors are responsible for the L-arginine paradox FEBS Lett 478 2000 1 3
35. R. Schneider, M. Meusel, and B. Betz Nitric oxide-induced regulation of renal organic cation transport after renal ischemia-reperfusion injury Am J Physiol Renal Physiol 301 2011 F997 1004
36. R. Schneider, M. Meusel, and S. Renker Low-dose indomethacin after ischemic acute kidney injury prevents downregulation of Oat1/3 and improves renal outcome Am J Physiol Renal Physiol 297 2009 F1614 F1621
37. N. Levin-Iaina, I. Schwartz, T. Chernichovsky, A. Davidovitch, A. Iaina, and D. Schwartz Tubular and glomerular L-arginine transport (uptake and transporters) and the nitric oxide synthases in ischemic acute renal failure (iARF) in streptozotocin-induced diabetic rats (STZ-DM) Renal Fail 29 2007 1031 1038